Universal Drug Coverage and Socioeconomic Disparities in Major Diabetes Outcomes

OBJECTIVE: Due in large part to effective pharmacotherapy, mortality rates have fallen substantially among those with diabetes; however, trends have been less favorable among those of lower socioeconomic status (SES), leading to a widening gap in mortality between rich and poor. We examined whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Booth, Gillian L., Bishara, Phoebe, Lipscombe, Lorraine L., Shah, Baiju R., Feig, Denice S., Bhattacharyya, Onil, Bierman, Arlene S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476904/
https://www.ncbi.nlm.nih.gov/pubmed/22891257
http://dx.doi.org/10.2337/dc12-0364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476904/
https://www.ncbi.nlm.nih.gov/pubmed/22891257
http://dx.doi.org/10.2337/dc12-0364

Ejemplares similares